Insiders who reported open-market trades in the last 12 months at the companies Iqbal J. Hussain files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Karen M. Anderson - $9.65M in CNTA purchases and sales in the last 12 months
Gregory M. Weinhoff - $2.65M in CNTA purchases and sales in the last 12 months
Tia L. Bush - $2.16M in CNTA purchases and sales in the last 12 months
Iqbal J. Hussain is a corporate insider, tracked as Chief Legal Officer of Centessa Pharmaceuticals plc (CNTA). InsiderAlpha holds 11 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Iqbal J. Hussain last file a Form 4?
The most recent primary Form 4 on record is dated 24 June 2026, one of 11 filings going back to 2024.
Has Iqbal J. Hussain been buying or selling stock?
Recorded transactions: 0 open-market purchases and 10 open-market sales ($3.74M) across all tracked filings.
Iqbal J. Hussain is Chief Legal Officer of Centessa Pharmaceuticals plc (CNTA). 11 SEC Form 4 filings on record going back to 2024, most recently on 24 June 2026. Most recent open-market trade: sold $980K of CNTA on 3 February 2026. Lifetime open-market sales: $3.74M.
Recent transactions
20
The latest 20 SEC Form 4 transactions reported by Iqbal J. Hussain.
InsiderAlpha's records for Iqbal J. Hussain go back to 2024: 11 primary Form 4 filings, an average of 3.7 per year. 9 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
